TMC-169, a new antibiotic of the aspochalasin group produced by Aspergillus flavipes

J Antibiot (Tokyo). 1999 Jun;52(6):575-7. doi: 10.7164/antibiotics.52.575.

Authors

J Kohno¹, N Nonaka, M Nishio, T Ohnuki, K Kawano, T Okuda, S Komatsubara

Affiliation

¹ Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Saitama, Japan.

PMID: 10470683
DOI: 10.7164/antibiotics.52.575

No abstract available

MeSH terms

Anti-Bacterial Agents / biosynthesis*
Anti-Bacterial Agents / chemistry
Anti-Bacterial Agents / pharmacology
Aspergillus / metabolism*
Bridged Bicyclo Compounds, Heterocyclic / chemistry
Bridged Bicyclo Compounds, Heterocyclic / metabolism
Bridged Bicyclo Compounds, Heterocyclic / pharmacology
Cell Death / drug effects
Chemical Phenomena
Chemistry, Physical
Chromatography, Gel
Chromatography, High Pressure Liquid
Fermentation
Humans
Magnetic Resonance Spectroscopy
Molecular Structure
Spectrophotometry
Tumor Cells, Cultured

Substances

Anti-Bacterial Agents
Bridged Bicyclo Compounds, Heterocyclic
TMC 169